Stem Cell-Based Therapies in Diabetes
Stem cell-based therapies have emerged as a potential treatment for diabetes by replacing damaged or dysfunctional beta cells with healthy ones. The use of pluripotent stem cells (PSCs) and induced pluripotent stem cells (iPSCs) has shown promising results in preclinical trials.
These cells can be differentiated into insulin-producing beta cells and transplanted back into the patient, potentially eliminating the need for insulin injections and improving diabetes management. However, there are still challenges to overcome, such as immune rejection and the need to optimize the differentiation protocols to increase the efficiency and functionality of the beta cells.